This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The retrospective study by Stranders et al¹ describing the relationship of elevated admission blood glucose levels (>200 mg/dL [>11.1 mmol/L]) in nondiabetic patients with acute myocardial infarction (AMI) and mortality is a useful addition to the literature on risk stratification in AMI. There are several points in this article that we would like to bring to the attention of the readers. First, in the study population, approximately 50% received thrombolytic or primary angioplasty and the remainder were managed conservatively, yet the in-hospital mortality of 2.5%, 7.1%, 6.9%, and 4.6%, respectively, in groups 1 through 4 is superior to that of most trials that managed with more aggressive strategies.² This finding would be unusual in a population of patients that had the number of in-hospital events as the study population. It would also have been helpful if the authors’ analyses considered additional factors that are known to be associated with short- . . . [Full Text of this Article]

AUTHOR INFORMATION
Ravi K. Bobba, MD; Edward L. Arsura, MD

RELATED ARTICLE

Admission Blood Glucose Level as Risk Indicator of Death After Myocardial Infarction in Patients With and Without Diabetes Mellitus
Ischa Stranders, Michaela Diamant, Rogier E. van Gelder, Hugo J. Spruijt, Jos W. R. Twisk, Robert J. Heine, and Frans C. Visser
Arch Intern Med. 2004;164(9):982-988.
ABSTRACT | FULL TEXT